The impact of the COVID-19 pandemic on the US trauma device market was relatively lesser due to the urgent nature of the procedures involved. Moving forward, the market’s growth will remain primarily fueled by favorable demographics, expansion in foot and ankle device segment and site-of-service flexibility, continuous improvement in physician training, and ongoing advancements in product innovation. However, increasing presence of competitors and bulk purchases of devices by US hospitals will drive ASPs downward, limiting market growth.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for trauma devices in the US from 2019 through 2032.
Trauma device procedure volume growth in the US will be primarily propelled by moderate expansion in specific high-volume segments.
Which anatomic segments contribute most strongly to overall procedure volumes?
Which devices do physicians prefer using to treat these anatomies?
Which anatomic segments are seeing increased interest from competitors, and why?
How are procedural trends shifting due to improved technology and clinical data?
MNCs have established a strong presence and hold a significant share in the US trauma device market.
Which MNCs have the strongest presence in the US market?
What strategies and factors will contribute to success in this region through 2032?
The impact of the COVID-19 pandemic and the reimbursement landscape for trauma procedures performed in ASC settings encourage a shift to outpatient and ASC settings for certain anatomies.
How has the COVID-19 pandemic influenced site-of-service trends?
Procedures for which anatomies are experiencing a site-of-service shift?
Which other value-based incentives and reimbursement model changes are impacting the US trauma device market?
Several manufacturers have recently expanded their product portfolios with the introduction of new devices or by acquiring companies with complementary products.
Which competitors are using the breadth of their product portfolios to sustain or increase their trauma device market shares?
Which new competitors will enter the external fixation device market?
How are competitors expanding their offerings through product innovation, mergers, acquisitions, and/or partnerships to capture a larger share of the trauma device market?